Last updated on March 2019

Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Non-Small-Cell Lung | Carcinoma
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other:
    Male or female patient older than 18 years. Adult patient diagnosed with stage IIIb/IV
    NSCLC locally advanced or metastatic, with activating mutation(s) of EGFR and who is
    EGFR-TKI naïve.
    Patient for whom a decision of treatment with afatinib monotherapy has been taken in the
    frame of its marketing authorization.
    Out-patient. Patient having given written consent for participation in the study. Patient
    who is able to participate in the investigator's opinion. Patient affiliated with the
    French social security.

You may not be eligible for this study if the following are true:

  • Patients participating in an interventional clinical study. Patients for whom a
    participation in an interventional clinical study is foreseen within 3 months following the
    tudy inclusion.
    Patients participating in a therapeutic education program.

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.